Diabetes and glaucoma.

The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol (2002) 16.89

The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol (2002) 11.38

Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study. Am J Ophthalmol (2004) 2.39

Reduction in intraocular pressure after cataract extraction: the Ocular Hypertension Treatment Study. Ophthalmology (2012) 2.35

Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension. Ophthalmology (2006) 2.28

Delaying treatment of ocular hypertension: the ocular hypertension treatment study. Arch Ophthalmol (2010) 2.14

The Ocular Hypertension Treatment Study: topical medication delays or prevents primary open-angle glaucoma in African American individuals. Arch Ophthalmol (2004) 2.03

Quality of life in keratoconus. Am J Ophthalmol (2004) 2.03

Baseline topographic optic disc measurements are associated with the development of primary open-angle glaucoma: the Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study. Arch Ophthalmol (2005) 1.80

Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study. Am J Ophthalmol (2006) 1.80

Classification of visual field abnormalities in the ocular hypertension treatment study. Arch Ophthalmol (2003) 1.76

The utility of the monocular trial: data from the ocular hypertension treatment study. Ophthalmology (2010) 1.61

Importance of vitreous liquefaction in age-related cataract. Invest Ophthalmol Vis Sci (2004) 1.56

Racial differences in optic disc topography: baseline results from the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study. Arch Ophthalmol (2004) 1.49

Baseline visual field characteristics in the ocular hypertension treatment study. Ophthalmology (2002) 1.46

Detection and prognostic significance of optic disc hemorrhages during the Ocular Hypertension Treatment Study. Ophthalmology (2006) 1.44

Is a history of diabetes mellitus protective against developing primary open-angle glaucoma? Arch Ophthalmol (2008) 1.43

Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure. Blood (2011) 1.37

The Ocular Hypertension Treatment Study: reproducibility of cup/disk ratio measurements over time at an optic disc reading center. Am J Ophthalmol (2002) 1.27

Adjusting intraocular pressure for central corneal thickness does not improve prediction models for primary open-angle glaucoma. Ophthalmology (2011) 1.23

Test-retest reproducibility of optic disk deterioration detected from stereophotographs by masked graders. Am J Ophthalmol (2005) 1.20

Changes in the quality-of-life of people with keratoconus. Am J Ophthalmol (2008) 1.18

Longitudinal and cross-sectional analyses of visual field progression in participants of the Ocular Hypertension Treatment Study. Arch Ophthalmol (2010) 1.18

Longitudinal changes in visual acuity in keratoconus. Invest Ophthalmol Vis Sci (2006) 1.18

The association between glaucomatous visual fields and optic nerve head features in the Ocular Hypertension Treatment Study. Ophthalmology (2006) 1.16

Estimation of the incidence and factors predictive of corneal scarring in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study. Cornea (2006) 1.11

Variability of intraocular pressure measurements in observation participants in the ocular hypertension treatment study. Ophthalmology (2009) 1.06

The confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study: study design and baseline factors. Am J Ophthalmol (2004) 1.06

Predicting the onset of glaucoma: the confocal scanning laser ophthalmoscopy ancillary study to theOcular Hypertension Treatment Study. Ophthalmology (2010) 1.05

Topical ocular hypotensive medication and lens opacification: evidence from the ocular hypertension treatment study. Am J Ophthalmol (2006) 1.05

Effect of treatment on the rate of visual field change in the ocular hypertension treatment study observation group. Invest Ophthalmol Vis Sci (2012) 1.03

The lifetime economic burden of keratoconus: a decision analysis using a markov model. Am J Ophthalmol (2011) 1.01

The rate of visual field change in the ocular hypertension treatment study. Invest Ophthalmol Vis Sci (2012) 0.98

Changes in central corneal thickness over time: the ocular hypertension treatment study. Ophthalmology (2008) 0.98

The impact of anchor point on utilities for 5 common ophthalmic diseases. Ophthalmology (2007) 0.98

Visual field quality control in the Ocular Hypertension Treatment Study (OHTS). J Glaucoma (2007) 0.97

Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study. Arch Ophthalmol (2005) 0.95

Asymmetries and visual field summaries as predictors of glaucoma in the ocular hypertension treatment study. Invest Ophthalmol Vis Sci (2006) 0.93

Series length used during trend analysis affects sensitivity to changes in progression rate in the ocular hypertension treatment study. Invest Ophthalmol Vis Sci (2013) 0.91

Baseline risk factors for the development of primary open-angle glaucoma in the Ocular Hypertension Treatment Study. Am J Ophthalmol (2004) 0.88

Comparison of flat and steep rigid contact lens fitting methods in keratoconus. Optom Vis Sci (2005) 0.87

Variables affecting rigid contact lens comfort in the collaborative longitudinal evaluation of keratoconus (CLEK) study. Optom Vis Sci (2004) 0.86

Association between visual parameters and neuroimaging features of idiopathic intracranial hypertension. J Neurol Sci (2013) 0.86

Differences in keratoconus as a function of gender. Am J Ophthalmol (2005) 0.85

Rate of visual field progression in eyes with optic disc hemorrhages in the ocular hypertension treatment study. Arch Ophthalmol (2012) 0.85

Seasonal changes in visual field sensitivity and intraocular pressure in the ocular hypertension treatment study. Ophthalmology (2013) 0.84

The incidence of retinal vein occlusion in the ocular hypertension treatment study. Ophthalmology (2010) 0.83

The development of a decision analytic model of changes in mean deviation in people with glaucoma: the COA model. Ophthalmology (2012) 0.82

Effect of patient's life expectancy on the cost-effectiveness of treatment for ocular hypertension. Arch Ophthalmol (2010) 0.81